brexit
UK must prioritise $17bn medtech sector in face of Brexit, new report urges
May 3, 2017Manufacturing and Production, Research and Development, Sales and Marketing Institution of Mechanical Engineers, brexit, general election, medtech
A new report from the Institution of Mechanical Engineers (IME) has highlighted the threat Brexit poses to the $17 billion …
Trials and Tribulations: The impact of new clinical trial regulation in Europe
April 11, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, UK, brexit, clinical trials, regulations
The clinical trial is the fulcrum on which drug development and treatment hinges. Even with the advent of new technologies …
Looming Brexit sparks fears for child cancer trials, experts warn
March 9, 2017Medical Communications, Research and Development EU, ICR, brexit
The trials of cancer treatments in the EU are already at a low level and Brexit has experts worried that …
Brexit could delay key drugs to UK patients, ex-MHRA chairman claims
February 10, 2017Medical Communications, Sales and Marketing Cancer, MHRA, brexit
Former UK regulator and ex-chairman of the Medicines and Healthcare products Regulatory Agency (MHRA) Sir Alasdair Breckenridge has warned that …
Novo Nordisk launches £115 million investment in UK despite Brexit
January 30, 2017Research and Development, Sales and Marketing Novo Nordisk, University of Oxford, brexit
Novo Nordisk has given the UK a boost by confirming that it plans to go ahead with a £115 million …
PM May announces Brexit plan, BioIndustry Association CEO reacts
January 18, 2017Research and Development, Sales and Marketing Theresa May, brexit
After months of uncertainty following the UK’s vote to leave the EU, Theresa May has finally announced the first inklings …
Theresa May promises £2 billion a year in funding for R&D
November 21, 2016Manufacturing and Production, Medical Communications Conservative, Theresa May, brexit
The Conservative Party leader has announced a planned raise in funding for research and development for UK business to £2 …
UK Biopharma and life after Brexit
September 15, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit
Originally published in the September issue of Pharmafocus, Paul Ranson of global law firm Morgan Lewis’ London Life Sciences Practice …
The September issue of Pharmafocus is now live!
August 31, 2016Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bristol-Myer's Squibb, Bristol-Myers Squibb, CDF, Cancer Drugs Fund, Cloud Computing, Pharmafocus, Pharmafocus new issue, brexit, clinical trial transparaency, opdivo
The latest edition of Pharmafocus is available online now. In this issue, we explore the future of the clinical trial …
UK Government commits to funding EU research projects after Brexit
August 15, 2016Manufacturing and Production, Research and Development brexit, research
Chancellor Phillip Hammond has outlined a government commitment to guarantee EU funding for British research projects made before Britain leaves …
Top ten stories in the pharmaceutical industry this week
August 5, 2016Medical Communications, Research and Development Actavis, Bioelectronics, CDF, Celgne, EMA, GSK, GlaxoSmithKline, Innovate UK, Medivation, NICE, Novartis, Roche, Sanofi, Teva, appointments, apremilast, biog, breast cancer, brexit, google, pharmaceutical industry, rheumatoid arthritis, sarilumab, top ten
It’s Friday, and we’ve seen some big developments in the industry’s headlines throughout the week, from news of Glaxo-Smith-Kilne’s new …
The impact of Brexit on the pharmaceutical industry: some preliminary considerations
August 1, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit
The outcome of the popular vote cast on 23 June 2016 will be remembered as the start of a new …
GSK announces significant post-Brexit UK investment
July 27, 2016Manufacturing and Production, Research and Development GSK, UK, brexit, investment
GlaxoSmithKline has given the UK life sciences industry a major boost in the post-Brexit landscape with an announcement that £275 …
“Immediate challenges” for UK pharma post-Brexit, says ABPI
June 24, 2016Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, brexit
The UK life sciences industry has expressed dismay at the result of the EU referendum, but has pledged to work …
EU referendum outcome will have major consequences for UK’s pharma sector – GlobalData
June 23, 2016Medical Communications, Sales and Marketing EMA, GlobalData, Pharma sector, brexit, referendum
The outcome of today’s referendum on the UK’s continuing membership of the European Union (EU) will have major consequences for …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
